2018
DOI: 10.1161/jaha.117.006462
|View full text |Cite|
|
Sign up to set email alerts
|

Left Ventricular Unloading Using an Impella CP Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure

Abstract: BackgroundDelivering therapeutic materials, like stem cells or gene vectors, to the myocardium is difficult in the setting of ischemic heart failure because of decreased coronary flow and impaired microvascular perfusion (MP). The aim of this study was to determine if mechanical left ventricular (LV) unloading with the Impella increases coronary flow and MP in a subacute myocardial infarction.Methods and ResultsAnterior transmural myocardial infarction (infarct size, 26.0±3.4%) was induced in Yorkshire pigs. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
54
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 68 publications
(61 citation statements)
references
References 35 publications
6
54
0
1
Order By: Relevance
“…Specifically, the Impella heart pump (Abiomed, Danvers, MA) is a catheter-based transaortic LV microaxial assist device that has been gaining in popularity and utilization ( 5 ). Owing to its position across the aortic valve, the Impella augments cardiac output and mean arterial pressure while simultaneously decreasing the workload of the heart ( 6 ) and increasing coronary blood flow into the infarct zone of the LV after myocardial infarction ( 7 ). Although this pleiotropic ability of the Impella device to stabilize hemodynamics and attenuate ischemic burden makes it a therapeutic candidate for CAD patients, no study has investigated the impact of Impella in a setting of dissected coronary artery.…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, the Impella heart pump (Abiomed, Danvers, MA) is a catheter-based transaortic LV microaxial assist device that has been gaining in popularity and utilization ( 5 ). Owing to its position across the aortic valve, the Impella augments cardiac output and mean arterial pressure while simultaneously decreasing the workload of the heart ( 6 ) and increasing coronary blood flow into the infarct zone of the LV after myocardial infarction ( 7 ). Although this pleiotropic ability of the Impella device to stabilize hemodynamics and attenuate ischemic burden makes it a therapeutic candidate for CAD patients, no study has investigated the impact of Impella in a setting of dissected coronary artery.…”
Section: Introductionmentioning
confidence: 99%
“…For example, TandemHeart was implanted during LCx occlusion (30 min) and effectively unloaded the LV while maintaining systemic pressure, which was evident via decreased stroke volume, end-diastolic volume, and EDP ( 151 ). Impella devices have also been investigated in swine ( 152 , 156 , 157 , 158 , 159 , 160 , 161 ) and ovine ( 162 , 163 ) models of adult and pediatric HF. Using their recently described combination I/R−coronary microembolization protocol in Yorkshire swine, Watanabe et al.…”
Section: The Translational Role Of Large Animal Models Of Hf: a Critimentioning
confidence: 99%
“…Using their recently described combination I/R−coronary microembolization protocol in Yorkshire swine, Watanabe et al. ( 159 ) examined mechanical LV unloading 2 weeks post-MI using the Impella CP. After 2 h of circulatory support, Impella decreased LV end-diastolic volume and EDP, maintained peripheral vascular pressure, and increased coronary vascular perfusion in the infarct area.…”
Section: The Translational Role Of Large Animal Models Of Hf: a Critimentioning
confidence: 99%
“…Additional potential benefits of primary LV unloading at the time of AMI such as improvement in microvascular perfusion were also reported in other studies. 31…”
Section: Unloading-pre Clinical Datamentioning
confidence: 99%